BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 15789965)

  • 1. Worksite influenza immunization programs. Insight into the implementation and cost-benefit.
    Olsen GW; Steinberg ME; Ley CA
    AAOHN J; 2005 Mar; 53(3):105-10. PubMed ID: 15789965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A worksite influenza immunization program. Impact on lost work days, health care utilization, and health care spending.
    Dille JH
    AAOHN J; 1999 Jul; 47(7):301-9. PubMed ID: 10661043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative workplace influenza program: boosting employee immunization rates.
    Strunk C
    AAOHN J; 2005 Oct; 53(10):432-7. PubMed ID: 16255525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worksite influenza immunization. Successful program.
    Dille JH
    AAOHN J; 1999 Jul; 47(7):292-300. PubMed ID: 10661042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scenarios on costs and savings of influenza treatment and prevention for Dutch healthy working adults.
    Postma MJ; Jansema P; Scheijbeler HW; van Genugten ML
    Vaccine; 2005 Nov; 23(46-47):5365-71. PubMed ID: 16029916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creating cost-effective flu shot programs.
    Epstein D
    Bus Health; 1998 Sep; 16(9 Suppl A):15-8. PubMed ID: 10185748
    [No Abstract]   [Full Text] [Related]  

  • 7. Modeling the impact of enhanced depression treatment on workplace functioning and costs: a cost-benefit approach.
    Lo Sasso AT; Rost K; Beck A
    Med Care; 2006 Apr; 44(4):352-8. PubMed ID: 16565636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination.
    Jean-Jasmin LM; Lynette SP; Stefan M; Kai CS; Chew FT; Wah LB
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):693-6. PubMed ID: 15689089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in influenza vaccine technology: a potential new prevention strategy for employers and managed care organizations.
    Williams JP; Lednar W
    Am J Manag Care; 2002 Apr; 8(5 Suppl):S143-54. PubMed ID: 11999801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and costs of immunizing children against influenza at school: an economic analysis based on a large-cluster controlled clinical trial.
    Schmier J; Li S; King JC; Nichol K; Mahadevia PJ
    Health Aff (Millwood); 2008; 27(2):w96-104. PubMed ID: 18216044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could a federal program to promote influenza vaccination among elders be cost-effective?
    Patel MS; Davis MM
    Prev Med; 2006 Mar; 42(3):240-6. PubMed ID: 16480761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential cost-effectiveness of annual influenza immunization for infants and toddlers: experience from Canada.
    Skowronski DM; Woolcott JC; Tweed SA; Brunham RC; Marra F
    Vaccine; 2006 May; 24(19):4222-32. PubMed ID: 16423432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and benefit-cost of peer-based workplace substance abuse prevention coupled with random testing.
    Miller TR; Zaloshnja E; Spicer RS
    Accid Anal Prev; 2007 May; 39(3):565-73. PubMed ID: 17125723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-influenza vaccination for active persons (25-64 years): a cost-benefit study].
    Levy E; Levy P
    Rev Epidemiol Sante Publique; 1992; 40(5):285-95. PubMed ID: 1480805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of influenza vaccination of healthy children.
    Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T
    Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic costs of influenza-related work absenteeism.
    Akazawa M; Sindelar JL; Paltiel AD
    Value Health; 2003; 6(2):107-15. PubMed ID: 12641861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of worksite health promotion programs on employee absenteeism. A comparative analysis.
    Conrad KM; Riedel JE; Gibbs JO
    AAOHN J; 1990 Dec; 38(12):573-80. PubMed ID: 2271070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case management approach to immunizing patients at high risk for influenza.
    Kreager AM; Cicerone J; Hella S; Johnson AN; Matthews L; Richards NL; Sinishtaj L; Tobin A; Veltigian S
    Lippincotts Case Manag; 2001; 6(4):138-42; quiz 143-5. PubMed ID: 16398063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.